NFKB1 and B-cell chronic lymphocytic leukemia: In CLL cells, a substantial body of evidence demonstrates the upregulation of NF-kB target genes, especially when malignant cells are exposed to stimuli of the microenvironment of lymphoid tissues that promote survival, proliferation, chemotaxis and drug resistance [131].